京新药业：辛伐他汀片中标集采对公司整体业绩不会构成重大影响
京新药业3月20日在投资者互动平台表示，近期长三角联盟集采，公司辛伐他汀片中标价格较前期国采价格略有提升，但该产品在公司成品药营收中占比不到5%，对公司整体业绩不会构成重大影响。
Statement:
The content of this article does not represent the views of fxgecko website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!
Related News
